-
Mashup Score: 1‘Incredibly rewarding’: FDA expands total artificial heart study after early success - 14 hour(s) ago
An additional 15 patients will now receive BiVacor’s titanium total artificial heart technology as they wait for a permanent transplant.
Source: cardiovascularbusiness.comCategories: General Medicine News, CardiologistsTweet
-
Mashup Score: 1
The first-in-human procedures were performed in Prague with the investigational Aveir CSP leadless pacemaker system.
Source: cardiovascularbusiness.comCategories: General Medicine News, CardiologistsTweet
-
Mashup Score: 1How one health system reduced lengths of stay, slashed readmissions after heart surgery - 3 day(s) ago
Remote patient monitoring helps clinicians track heart patients as they recover from major operations. One surgeon described the technology as a “game-changer,” highlighting the confidence patients feel when they have “an extra set of eyes on them.”
Source: cardiovascularbusiness.comCategories: General Medicine News, CardiologistsTweet
-
Mashup Score: 9
New expert recommendations from the American College of Cardiology were designed to help cardiologists, primary care physicians, emergency physicians, rheumatologists and other clinicians deliver the best care possible when managing suspected myocarditis.
Source: cardiovascularbusiness.comCategories: General Medicine News, CardiologistsTweet
-
Mashup Score: 0ACC Young Scholars Program Nurtures the Next Generation of Cardiologists - American College of Cardiology - 8 day(s) ago
Contact: Julie Boyland, Jboyland@acc.org , A group of 114 promising high school and undergraduate students have been selected for the 2024 – 2025 ACC Young Scholars Program where they will participate in a year-long education and mentorship program to explore the diverse career paths within the field of cardiology. “The Young Scholars program brings together the best and the brightest young students in the U.S., fostering the next generation of cardiovascular professionals,” said ACC President Cathleen
Source: www.acc.orgCategories: General Medicine News, CardiologistsTweet-
A group of promising young students have been selected for the 2024 – 2025 ACC Young Scholars Program where they will participate in a year-long education & mentorship program to explore the diverse career paths within the field of #Cardiology. Read more: https://t.co/fhjNBqQB18 https://t.co/y7apsd8xZV
-
-
Mashup Score: 1
Heart failure (HF) is currently classified into three categories, according to left ventricular (LV) ejection fraction (LVEF): HF with reduced ejection fraction (HFrEF; LVEF <40%), HF with mid-range ejection fraction (HFmrEF; LVEF 40–49%) and HF with preserved ejection fraction (HFpEF; LVEF ≥50%). While HFrEF patients are usually male and have a history of coronary artery disease, acute myocardial infarction or idiopathic dilated cardiomyopathy, the clinical spectrum of HFpEF has proven to be much more heterogeneous.
Source: www.ejinme.comCategories: General Medicine News, CardiologistsTweet
-
Mashup Score: 0
The heightened risks were even seen in women who were never diagnosed with a psychiatric disorder. It remains unclear why the same trend was not seen in men.
Source: cardiovascularbusiness.comCategories: General Medicine News, CardiologistsTweet
-
Mashup Score: 0Cardiology Month in Review: November 2024 - 15 day(s) ago
Our Cardiology Month in Review for November 2024 spotlights the approval of acoramidis and top content from AHA 2024.
Source: www.hcplive.comCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 0Clopidogrel vs. aspirin: Tracking the chronic maintenance period after PCI for different risk groups - 15 day(s) ago
As more high-risk patients undergo PCI, what is the best antiplatelet strategy following an initial event-free period of DAPT? Does it change after complex PCI? Researchers aimed to answer these questions, and many others, with new findings published in JAMA Cardiology.
Source: cardiovascularbusiness.comCategories: General Medicine News, Cardiology News and JournTweet
-
Mashup Score: 0Cardiology Month in Review: November 2024 - 16 day(s) ago
Our Cardiology Month in Review for November 2024 spotlights the approval of acoramidis and top content from AHA 2024.
Source: www.hcplive.comCategories: General Medicine News, General HCPsTweet
‘Incredibly rewarding’: FDA expands total artificial heart study after early success #cardiology @bivacor https://t.co/FApPduXidz